← SynDRA

ACRIVASTINE

SynDRA canonical compound SYN0004722 — structure-anchored drug synonym record

All known targets

• HRH1
• ABCB1

Mechanisms of action (all sources)

• HRH1 ANTAGONIST
• Histamine H1 receptor antagonist
• histamine receptor antagonist

Bioactivity evidence (ChEMBL activities table — not curator-asserted)

• SLC6A4
• ADRA1A
• ADORA1
• NR1I2
• HTR1A
• HTR2A
• HTR2B
• HTR2C
• HTR3A
• KCNH2
• MAOA
• MC3R
• MLNR
• NPY1R
• OPRD1
• NR3C1
• HRH2
• OPRK1
• OPRM1
• PDE3A
• PDE4D
• PGR
• PTGS2
• SLC29A1
• SLC6A2
• SLC6A3
• HRH3
• HDAC6
• ADORA2A
• GHSR
• ADORA3
• ADRA2A
• ADRA2B
• ADRA2C
• ADRB1
• ADRB2
• AGTR1
• ALB
• AVPR1A
• AVPR2

Drug classes

• Histamine H1 Receptor Antagonists
• Histamine-1 Receptor Antagonist
• Histamine Agents
• Histamine Antagonists
• Histamine H1 Antagonists
• Histamine H1 Antagonists, Non-Sedating
• Neurotransmitter Agents

ATC classes

• R06A · ANTIHISTAMINES FOR SYSTEMIC USE

Cross-references

• PubChem CID: 5284514
• ChEMBL: CHEMBL1224
• DrugBank: DB09488
• ChEBI: CHEBI:83168
• KEGG: D02760
• RxNorm: 19959
• Wikipedia: Acrivastine
• TTD: D0O4EU

Synonyms

• SEMPREX-D
• BW-270C
• BW-825C
• semprex
• Acrivastina
• Acrivastine component of semprex-d
• Benadryl allgy relief plus decongest
• Semprex
• Acrivastin
• Acrivastinum
• Acrivastina [Spanish]
• Acrivastinum [Latin]
• Benadryl allergy relief
• BW 0270C
• BW A825C
• Acrivastine (USAN/INN)
• Acrivastine [USAN:INN:BAN]
• E-(9CI)
• BW 825C
• A20F9XAI7W
• CHEBI:83168
• DTXCID702555
• Benadryl Allgy Relief Plus Decongest
• BW825C
• RefChem:552703
• R06AX18
• MFCD00869830
• NCGC00182053-02
• UNII-A20F9XAI7W
• Acrivastine (Standard)
• ACRIVASTINE [MI]
• ACRIVASTINE [INN]
• ACRIVASTINE [USAN]
• ACRIVASTINE [VANDF]
• SCHEMBL4702
• ACRIVASTINE [MART.]
• ACRIVASTINE [WHO-DD]
• MLS006010115

Reported adverse events

• Dizziness
• Somnolence
• Asthenia
• Cough
• Dyspepsia
• Headache
• Insomnia
• Nausea
• Nervousness
• Pharyngitis